Biological efficacy of zinc oxide nanoparticles against diabetes: a preliminary study conducted in mice
Open Access
- 7 April 2020
- journal article
- research article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 40 (4)
Abstract
The antidiabetic, hypoglycemic and oral glucose tolerance test (OGTT) activities of zinc oxide nanoparticles (ZnONPs) were assessed in mice. ZnONPs were prepared by reacting Zn(NO3)2.6H2O and NaOH solution at 70°C with continuous stirring and then characterized by transmission electron microscopy (TEM) and scanning electron microscopy (SEM) techniques. Diabetes was induced by the intraperitoneal injection of streptozotocin (STZ) in mice, and then the blood glucose levels were determined by the glucose oxidase method. The experimental results revealed that ZnONPs suggestively (p<0.001) declined the blood glucose levels (39.79%), while these reductions were 38.78% for the cotreatment of ZnONPs and insulin, and 48.60% for insulin, respectively. In the hypoglycemic study, ZnONPs (8 and 14 mg/kg b.w) reduced approximately 25.13 and 29.15% of blood glucose levels, respectively. A similar reduction was found in the OGTT test, which is also a dose- and time-dependent manner. Overall, ZnONPs possess a potential antidiabetic activity, which could be validated by further mechanistic studies.Keywords
This publication has 34 references indexed in Scilit:
- Hormonal Regulation of Hepatic Glucose Production in Health and DiseaseCell Metabolism, 2011
- Oral Administration of Bis(aspirinato)zinc(II) Complex Ameliorates Hyperglycemia and Metabolic Syndrome-Like Disorders in Spontaneously Diabetic KK-Ay Mice: Structure-Activity Relationship on Zinc-Salicylate ComplexesChemical and Pharmaceutical Bulletin, 2011
- Current views on type 2 diabetesJournal of Endocrinology, 2009
- Zinc and diabetes — clinical links and molecular mechanismsThe Journal of Nutritional Biochemistry, 2009
- SLC30A3 Responds to Glucose- and Zinc Variations in ß-Cells and Is Critical for Insulin Production and In Vivo Glucose-Metabolism During ß-Cell StressPLOS ONE, 2009
- A Zinc(II)/Poly(γ‐glutamic acid) Complex as an Oral Therapeutic for the Treatment of Type‐2 Diabetic KKAy MiceMacromolecular Bioscience, 2009
- Prospective Study of Zinc Intake and Risk of Type 2 Diabetes in WomenDiabetes Care, 2009
- Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet beta-cells to potentiate insulin secretionPurinergic Signalling, 2008
- Zinc supplementation for the treatment or prevention of disease: Current status and future perspectivesExperimental Gerontology, 2008
- Emergency interventions for hyperkalaemiaCochrane Database of Systematic Reviews, 2005